title: Glycosaminoglycan profile in macrophages exposed to Candida albicans and interleukins.
abstract: Glycosaminoglycans (GAG), are extracellular matrix macromolecules that affect the phagocytic properties of macrophages. In order to assess whether the interaction between macrophages and Candida albicans (iCa) provokes changes in the phenotype, we analyzed the GAG profiles in two macrophage lines, ANA-1 (from murine bone-marrow) and BV-2 (from murine brain). We also investigated GAG modulation by interleukin-1alpha (IL-1alpha) and interleukin-6 (IL-6). During iCa treatment and even after the addition of ILs, ANA-1 accumulated less total GAG compared to controls. IL-1 treatment, combined with iCa exposure, induced a decrease in heparan sulfate and chondroitin sulfate chains, and an increase in the hyaluronic acid percentage. IL-6 treatment, with or without iCa, decreased the hyaluronic acid/sulfated GAG ratio. The GAG pattern in BV-2 appears to be different to ANA-1 and iCa exposure does not induce any difference in total GAG. The inhibitory effect induced by ILs on GAG synthesis is less than that observed in ANA-1 and the GAG elution profile is modulated to a lesser extent by treatment with ILs and/or iCa compared to the ANA-1. We suggest that the observed changes in the expression of the individual GAG classes may be responsible for the macrophage functional heterogeneity.
authors.affiliation: Dipartimento di Morfologia ed Embriologia, Università di Ferrara, Italy. pzf@ifeuniv.unife.it
authors.forename: M
authors.initials: M
authors.lastname: Bodo
authors.forename: E
authors.initials: E
authors.lastname: Blasi
authors.forename: E
authors.initials: E
authors.lastname: Becchetti
authors.forename: M
authors.initials: M
authors.lastname: Giammarioli
authors.forename: C
authors.initials: C
authors.lastname: Conte
authors.forename: S
authors.initials: S
authors.lastname: Bellocchio
authors.forename: T
authors.initials: T
authors.lastname: Baroni
authors.forename: C
authors.initials: C
authors.lastname: Bellucci
authors.forename: F
authors.initials: F
authors.lastname: Bistoni
mesh_terms: D000818:Animals; D001854:Bone Marrow Cells / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism / Q000382:microbiology; D001921:Brain / Q000166:cytology; D002176:Candida albicans / Q000502:physiology*; D002807:Chondroitin / Q000378:metabolism; D002809:Chondroitin Sulfates / Q000378:metabolism; D003871:Dermatan Sulfate / Q000378:metabolism; D005109:Extracellular Matrix / Q000737:chemistry; D006025:Glycosaminoglycans / Q000032:analysis* / Q000737:chemistry / Q000378:metabolism; D006497:Heparan Sulfate / Q000378:metabolism; D006820:Hyaluronic Acid / Q000378:metabolism; D007375:Interleukin-1 / Q000494:pharmacology*; D015850:Interleukin-6 / Q000494:pharmacology*; D008264:Macrophages / Q000737:chemistry* / Q000187:drug effects / Q000378:metabolism / Q000382:microbiology; D051379:Mice; D008810:Mice, Inbred C57BL
chemical_list: D002807:Chondroitin; D002809:Chondroitin Sulfates; D003871:Dermatan Sulfate; D006025:Glycosaminoglycans; D006497:Heparan Sulfate; D006820:Hyaluronic Acid; D007375:Interleukin-1; D015850:Interleukin-6